Kamal Faiza A, Fernet Lucas Y, Da Silva Naofal K, Briceño Gabriela, Iyoob Nusrath, Aleman Paredes Kenneth, Martinez Ramirez Marily, Arruarana Victor S
General Practice, University of Nottingham, Nottingham, GBR.
Surgery, Baptist Hospital of Miami, Miami, USA.
Cureus. 2024 Feb 12;16(2):e54094. doi: 10.7759/cureus.54094. eCollection 2024 Feb.
In this systematic review, the perioperative outcomes of total intravenous anesthesia (TIVA) and volatile anesthesia were compared in obese adults (BMI ≥ 30 kg/m²) undergoing elective surgery. The review analyzed data from 12 randomized-controlled trials involving 935 patients, sourced from PubMed/MEDLINE (Medical Literature Analysis and Retrieval System Online), Cochrane, Scopus, and Web of Science databases. The focus was on intraoperative vital signs, emergence time, postoperative nausea and vomiting (PONV), duration of post-anesthesia care unit (PACU) stay, and ICU admission rates. Findings showed that TIVA (using propofol) might reduce PONV, but there were no significant differences in other outcomes compared to volatile anesthesia (with desflurane as the most common agent). The review highlights the need for more research, especially comparing sevoflurane with TIVA, to establish clear clinical guidelines for anesthesia in obese patients.
在这项系统评价中,对接受择期手术的肥胖成年人(体重指数≥30kg/m²)采用全静脉麻醉(TIVA)和挥发性麻醉的围手术期结局进行了比较。该评价分析了来自12项随机对照试验的数据,涉及935例患者,数据来源于PubMed/MEDLINE(医学文献分析与联机检索系统)、Cochrane、Scopus和科学网数据库。重点关注术中生命体征、苏醒时间、术后恶心呕吐(PONV)、麻醉后监护病房(PACU)停留时间以及重症监护病房(ICU)入住率。结果显示,TIVA(使用丙泊酚)可能会减少PONV,但与挥发性麻醉(以地氟醚为最常用药物)相比,其他结局并无显著差异。该评价强调需要开展更多研究,尤其是比较七氟醚与TIVA,以制定针对肥胖患者麻醉的明确临床指南。